BROWN & BROWN, INC. Debt Disclosure
NOTE 8 Long-Term Debt
Long-term debt at December 31, 2025 and 2024 consisted of the following, with certain prior-period amounts having been reclassified to conform to the current-period presentation.
(in millions) |
|
December 31, |
|
|
December 31, |
|
||
Current portion of long-term debt: |
|
|
|
|
|
|
||
Current portion of 5-year term loan facility expires 2026 |
|
$ |
169 |
|
|
$ |
25 |
|
Current portion of 3-year term loan facility expired 2025 |
|
|
— |
|
|
|
150 |
|
4.600% senior notes, semi-annual interest payments, balloon due 2026 |
|
|
400 |
|
|
|
— |
|
Current portion of 5-year revolving loan facility, periodic interest payments, |
|
|
100 |
|
|
|
— |
|
Current portion of 5-year term loan facility expires 2027 |
|
|
50 |
|
|
|
50 |
|
Total current portion of long-term debt |
|
|
719 |
|
|
|
225 |
|
Long-term debt: |
|
|
|
|
|
|
||
Note agreements: |
|
|
|
|
|
|
||
4.700% senior notes, semi-annual interest payments, balloon due 2028 |
|
|
500 |
|
|
|
— |
|
4.500% senior notes, semi-annual interest payments, balloon due 2029 |
|
|
350 |
|
|
|
350 |
|
4.900% senior notes, semi-annual interest payments, balloon due 2030 |
|
|
800 |
|
|
|
— |
|
2.375% senior notes, semi-annual interest payments, balloon due 2031 |
|
|
700 |
|
|
|
700 |
|
4.200% senior notes, semi-annual interest payments, balloon due 2032 |
|
|
600 |
|
|
|
600 |
|
5.250% senior notes, semi-annual interest payments, balloon due 2032 |
|
|
500 |
|
|
|
— |
|
5.650% senior notes, semi-annual interest payments, balloon due 2034 |
|
|
600 |
|
|
|
600 |
|
5.550% senior notes, semi-annual interest payments, balloon due 2035 |
|
|
1,000 |
|
|
|
— |
|
4.950% senior notes, semi-annual interest payments, balloon due 2052 |
|
|
600 |
|
|
|
600 |
|
6.250% senior notes, semi-annual interest payments, balloon due 2055 |
|
|
1,000 |
|
|
|
— |
|
Total notes |
|
|
6,650 |
|
|
|
2,850 |
|
Credit agreements: |
|
|
|
|
|
|
||
5-year term loan facility, periodic interest and principal payments, expires October 27, 2026 |
|
|
— |
|
|
|
169 |
|
5-year revolving loan facility, periodic interest payments, %, |
|
|
— |
|
|
|
250 |
|
5-year term loan facility, periodic interest and principal payments, %, |
|
|
313 |
|
|
|
362 |
|
Total credit agreements |
|
|
313 |
|
|
|
781 |
|
Unamortized portion of debt discounts related to note agreements (contra) |
|
|
(18 |
) |
|
|
(11 |
) |
Debt issuance costs (contra) |
|
|
(51 |
) |
|
|
(21 |
) |
Total long-term debt, less unamortized discount and debt issuance costs |
|
|
6,894 |
|
|
|
3,599 |
|
Current portion of long-term debt |
|
|
719 |
|
|
|
225 |
|
Total debt |
|
$ |
7,613 |
|
|
$ |
3,824 |
|
Note agreements: On June 11, 2025, the Company entered into an Underwriting Agreement with BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein, with respect to the offer and sale by the Company of $400 million principal amount of its 4.600% Senior Notes due 2026 (the “2026 Notes”), $500 million principal amount of its 4.700% Senior Notes due 2028 (the “2028 Notes”), $800 million principal amount of its 4.900% Senior Notes due 2030 (the “2030 Notes”), $500 million principal amount of its 5.250% Senior Notes due 2032 (the “2032 Notes”), $1,000 million principal amount of its 5.550% Senior Notes due 2035 (the “2035 Notes”) and $1,000 million principal amount of its 6.250% Senior Notes due 2055 (the “2055 Notes” and, together with the 2026 Notes, the 2028 Notes, the 2030 Notes, the 2032 Notes, and the 2035 Notes, the “Notes”). The Company used the net proceeds of the offering of the Notes, together with the proceeds from the offering of shares of common stock and cash on hand, to fund the cash consideration payable under the Merger Agreement, and to pay fees and expenses associated with the foregoing. As of December 31, 2025, the aggregate outstanding balance of the Notes was $4,200 million, exclusive of the associated discount balance.
The Company maintains notes from other issuances aggregating to a total outstanding debt balance of $2,850 million, exclusive of the associated discount balance, as of December 31, 2025 and December 31, 2024.
Credit agreements: On March 31, 2025, the Company repaid the outstanding balance on the 3-year term loan facility of $150 million.
The Company has credit agreements that include term loans and a Revolving Credit Facility of $800 million, all having similar terms and covenants. The outstanding balance on the term loans was $532 million and $756 million as of December 31, 2025 and December 31, 2024, respectively. There was an outstanding balance of $100 million on the Revolving Credit Facility as of December 31, 2025, and $250 million outstanding as of December 31, 2024.
The Company is required to maintain certain financial ratios and comply with certain other covenants related to outstanding credit agreements. The Company was in compliance with all such covenants as of December 31, 2025 and December 31, 2024.
At December 31, 2025, the for the term loan due October 2026 and the term loan due March 2027 was 3.716%. The on the Revolving Credit Facility due October 2026 was 3.843% as of December 31, 2025. These rates are inclusive of a 0.100% credit-spread adjustment per the terms of the relevant agreements.
Interest paid in 2025, 2024 and 2023 was $284 million, $195 million, and $186 million, respectively.
At December 31, 2025, maturities of long-term debt are $719 million in 2026, $313 million in 2027, $500 million in 2028, $350 million in 2029, $800 million in 2030 and $5,000 million thereafter.
On February 10, 2026, the Company drew down on the Revolving Credit Facility by $225 million, and the proceeds will be used for general corporate purposes, which may include, among other things, funding for working capital, capital expenditures, repurchases of our capital stock, acquisitions and repayment of our existing debt.
Fair value information about financial instruments not measured at fair value
The following tables presents liabilities that are not measured at fair value on a recurring basis:
|
|
December 31, 2025 |
|
|
December 31, 2024 |
|
||||||||||
(in millions) |
|
Carrying Value |
|
|
Fair Value |
|
|
Carrying Value |
|
|
Fair Value |
|
||||
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Current portion of long-term debt |
|
$ |
400 |
|
|
$ |
402 |
|
|
$ |
— |
|
|
$ |
— |
|
Long-term debt |
|
$ |
6,632 |
|
|
$ |
6,600 |
|
|
$ |
2,839 |
|
|
$ |
2,602 |
|
The carrying value of the Company's borrowings under various credit agreements approximates its fair value due to the variable interest rate based upon adjusted SOFR. The fair values above, which exclude accrued interest, are not necessarily indicative of the amounts that the Company would realize upon disposition, nor do they indicate the Company’s intent or ability to dispose of the financial instruments. The fair values of our senior notes are considered Level 2 financial instruments, as their values are measured by using observable inputs, other than quoted prices in active markets.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 12, 2026 | Showing above |
| 2024 | Feb 13, 2025 | |
| 2023 | Feb 22, 2024 | |
| 2022 | Feb 27, 2023 | |
| 2021 | Feb 23, 2022 | |
| 2020 | Feb 23, 2021 | |
| 2019 | Feb 24, 2020 | |
| 2018 | Feb 26, 2019 | |
| 2017 | Feb 28, 2018 | |
| 2016 | Feb 24, 2017 | |
| 2015 | Feb 26, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.